Traditional endocrine drugs, such as bicalutamide, are the first choice for neoadjuvant therapy of prostate cancer. There are few reports on the use of new endocrine drugs in neoadjuvant therapy in China. The patient, male, 63 years old. He was admitted to the hospital for the finding of pro...
The article reports on a study by doctor Antti Kaipia and colleagues which shows that androgen deprivation therapy (ADT) is being often used for low-risk prostate cancer (PCa). The study shows the link between the use ...
For patients with localizedprostate cancerwho undergo radiotherapy, giving androgen deprivation therapy (ADT) in the adjuvant setting leads to better oncologic outcomes than occur with up-front neoadjuvant ADT, which is how it is usually given. This new finding comes from an analysis of individual p...
However, the longer duration of ADT did not improve overall survival (HR, 0.88). Dr Chris Parker "Generally speaking, men who are having postoperative radiotherapy for prostate cancer usually do well and do not develop metastasis in 10 years," said lead author Chris Parker, MD, consultant clin...
FDA approves darolutamide tablets for metastatic hormone-sensitive prostate cancer. News. FDA. August 5, 2022. Accessed October 14, 2024. https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-darolutamide-tablets-metastatic-hormone-sensitive-prostate-cancerRelated...
for cases where other therapeutic options have either failed to “cure” the cancer and the case has advanced to the point where any further treatments aimed at “cure” would be fruitless and drastically reduce the patient’s quality of life. Palliative care is therefore for symptomatic relief....
Prostate cancer that has metastasized is treated with radiation or surgery along with drugs that block the hormones the tumors rely on to grow and spread. Androgen deprivation therapy (ADT) uses medications to block the action of hormones like testosterone that promotes male sex characteristics. ...
We are looking forward to future outcomes of our clinical development program investigating the compound across multiple prostate cancer stages and indications.” Darolutamide is currently indicated by the FDA for use in combination with docetaxel for the treatment of patients with...
Prostate cancer (PCa), the most commonly diagnosed cancer and second leading cause of male cancer death in Western societies, is typically androgen-depende... D Andrea,H Isabel,O Philipp,... - 《Nutrients》 被引量: 14发表: 2014年 Over The Counter Drugs (and Dietary Supplement) Exercise: ...
New drugs combination could save 20,000 men; Breakthrough study into prostate cancer treatment Radical prostatectomy and/or radiotherapy are the treatment modalities adopted for organ confined prostate cancer however androgen deprivation therapy (ADT) is the essential part of standard treatment for men ...